4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-25-000016
Chief Financial Officer sold 1,784 shares at $10.67 ($19,035)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| WENTWORTH KORY JAMES Chief Financial Officer | 2025-03-17 | Sale 10b5-1 | −1,784 | $10.67 | $19,035 | 109,536 | D: show line 1 in the form |
| Open-market sales · 1,784 sh · avg $10.67 · $19,035 | |||||||
Loading xslF345X05/wk-form4_1742416340.xml…